References
- Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10–24.
- Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N. Emergence of non-albicans Candida species in neonatal candidemia. N Am J Med Sci. 2013;5:541–5.
- Goel N, Ranjan PK, Aggarwal R, Chaudhary U, Sanjeev N. Emergence of non-albicans Candida in neonatal septicemia and antifungal susceptibility: experience from a tertiary care center. J Lab Physicians. 2009;1:53–5.
- Kang K, Fong WP, Tsang PW. Antifungal activity of baicalein against Candida krusei does not involve apoptosis. Mycopathologia. 2010;170:391–6.
- Wenzel RP, Gennings C. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin Infect Dis. 2005;41:S389–93.
- Pemán J, Cantón E, Espinel-Ingroff A. Antifungal drug resistance mechanisms. Expert Rev Anti Infect Ther. 2009;7:453–60.
- Morschhäuser J. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol. 2010;47:94–106.
- Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology. 2010;98:15–25.
- Zhou M, Luo H, Li Z, Wu F, Huang C, Ding Z, et al. Recent advances in screening of natural products for antimicrobial agents. Comb Chem High Throughput Screen. 2012;15:306–15.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Document M27-A2. Wayne, PA: CLSI; 2005.
- Kang K, Fong WP, Tsang PWK. Novel antifungal activity of purpurin against Candida species in vitro. Med Mycol. 2010;48:904–11.